Soluble hemojuvelin in transfused and untransfused thalassaemic subjects
Objective The hemojuvelin‐bone morphogenetic protein axis is the principal iron‐dependent mechanism of hepcidin regulation. The determination of soluble hemojuvelin (sHJV) levels could allow for a better understanding of the pathophysiological mechanisms of hepcidin regulation in thalassaemia. Metho...
Saved in:
Published in | European journal of haematology Vol. 98; no. 1; pp. 67 - 74 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Wiley Subscription Services, Inc
01.01.2017
|
Subjects | |
Online Access | Get full text |
ISSN | 0902-4441 1600-0609 1600-0609 |
DOI | 10.1111/ejh.12786 |
Cover
Abstract | Objective
The hemojuvelin‐bone morphogenetic protein axis is the principal iron‐dependent mechanism of hepcidin regulation. The determination of soluble hemojuvelin (sHJV) levels could allow for a better understanding of the pathophysiological mechanisms of hepcidin regulation in thalassaemia.
Method
We have assessed sHJV in 45 transfused and 15 untransfused thalassaemic patients in comparison with 15 healthy subjects, evaluating its relationships with some parameters of iron overload, anaemia and erythropoiesis.
Results
Untransfused thalassaemic patients had more severe anaemia and erythropoietic activity, while in transfused patients, the transfused RBCs reduced % reticulocytes and sTfR, increased serum indices of iron overload and iron stores in the liver (low MRI T2* values). sHJV levels were higher in patients than in controls and in untransfused in comparison with transfused patients. In the transfused group, we also found that sHJV values are significantly related to serum ferritin, cardiac MRI T2* and growth differentiation factor 15 and are sensitive to hepatitis C virus infection.
Conclusion
These results suggest that sHJV synthesis seems to be affected by an erythropoietic/hypoxic signal in untransfused patients that have severe anaemia, while in regularly transfused subjects, it is influenced by iron stores. |
---|---|
AbstractList | The hemojuvelin-bone morphogenetic protein axis is the principal iron-dependent mechanism of hepcidin regulation. The determination of soluble hemojuvelin (sHJV) levels could allow for a better understanding of the pathophysiological mechanisms of hepcidin regulation in thalassaemia.OBJECTIVEThe hemojuvelin-bone morphogenetic protein axis is the principal iron-dependent mechanism of hepcidin regulation. The determination of soluble hemojuvelin (sHJV) levels could allow for a better understanding of the pathophysiological mechanisms of hepcidin regulation in thalassaemia.We have assessed sHJV in 45 transfused and 15 untransfused thalassaemic patients in comparison with 15 healthy subjects, evaluating its relationships with some parameters of iron overload, anaemia and erythropoiesis.METHODWe have assessed sHJV in 45 transfused and 15 untransfused thalassaemic patients in comparison with 15 healthy subjects, evaluating its relationships with some parameters of iron overload, anaemia and erythropoiesis.Untransfused thalassaemic patients had more severe anaemia and erythropoietic activity, while in transfused patients, the transfused RBCs reduced % reticulocytes and sTfR, increased serum indices of iron overload and iron stores in the liver (low MRI T2* values). sHJV levels were higher in patients than in controls and in untransfused in comparison with transfused patients. In the transfused group, we also found that sHJV values are significantly related to serum ferritin, cardiac MRI T2* and growth differentiation factor 15 and are sensitive to hepatitis C virus infection.RESULTSUntransfused thalassaemic patients had more severe anaemia and erythropoietic activity, while in transfused patients, the transfused RBCs reduced % reticulocytes and sTfR, increased serum indices of iron overload and iron stores in the liver (low MRI T2* values). sHJV levels were higher in patients than in controls and in untransfused in comparison with transfused patients. In the transfused group, we also found that sHJV values are significantly related to serum ferritin, cardiac MRI T2* and growth differentiation factor 15 and are sensitive to hepatitis C virus infection.These results suggest that sHJV synthesis seems to be affected by an erythropoietic/hypoxic signal in untransfused patients that have severe anaemia, while in regularly transfused subjects, it is influenced by iron stores.CONCLUSIONThese results suggest that sHJV synthesis seems to be affected by an erythropoietic/hypoxic signal in untransfused patients that have severe anaemia, while in regularly transfused subjects, it is influenced by iron stores. Objective The hemojuvelin-bone morphogenetic protein axis is the principal iron-dependent mechanism of hepcidin regulation. The determination of soluble hemojuvelin (sHJV) levels could allow for a better understanding of the pathophysiological mechanisms of hepcidin regulation in thalassaemia. Method We have assessed sHJV in 45 transfused and 15 untransfused thalassaemic patients in comparison with 15 healthy subjects, evaluating its relationships with some parameters of iron overload, anaemia and erythropoiesis. Results Untransfused thalassaemic patients had more severe anaemia and erythropoietic activity, while in transfused patients, the transfused RBCs reduced % reticulocytes and sTfR, increased serum indices of iron overload and iron stores in the liver (low MRI T2* values). sHJV levels were higher in patients than in controls and in untransfused in comparison with transfused patients. In the transfused group, we also found that sHJV values are significantly related to serum ferritin, cardiac MRI T2* and growth differentiation factor 15 and are sensitive to hepatitis C virus infection. Conclusion These results suggest that sHJV synthesis seems to be affected by an erythropoietic/hypoxic signal in untransfused patients that have severe anaemia, while in regularly transfused subjects, it is influenced by iron stores. The hemojuvelin-bone morphogenetic protein axis is the principal iron-dependent mechanism of hepcidin regulation. The determination of soluble hemojuvelin (sHJV) levels could allow for a better understanding of the pathophysiological mechanisms of hepcidin regulation in thalassaemia. We have assessed sHJV in 45 transfused and 15 untransfused thalassaemic patients in comparison with 15 healthy subjects, evaluating its relationships with some parameters of iron overload, anaemia and erythropoiesis. Untransfused thalassaemic patients had more severe anaemia and erythropoietic activity, while in transfused patients, the transfused RBCs reduced % reticulocytes and sTfR, increased serum indices of iron overload and iron stores in the liver (low MRI T2* values). sHJV levels were higher in patients than in controls and in untransfused in comparison with transfused patients. In the transfused group, we also found that sHJV values are significantly related to serum ferritin, cardiac MRI T2* and growth differentiation factor 15 and are sensitive to hepatitis C virus infection. These results suggest that sHJV synthesis seems to be affected by an erythropoietic/hypoxic signal in untransfused patients that have severe anaemia, while in regularly transfused subjects, it is influenced by iron stores. Objective The hemojuvelin‐bone morphogenetic protein axis is the principal iron‐dependent mechanism of hepcidin regulation. The determination of soluble hemojuvelin (sHJV) levels could allow for a better understanding of the pathophysiological mechanisms of hepcidin regulation in thalassaemia. Method We have assessed sHJV in 45 transfused and 15 untransfused thalassaemic patients in comparison with 15 healthy subjects, evaluating its relationships with some parameters of iron overload, anaemia and erythropoiesis. Results Untransfused thalassaemic patients had more severe anaemia and erythropoietic activity, while in transfused patients, the transfused RBCs reduced % reticulocytes and sTfR, increased serum indices of iron overload and iron stores in the liver (low MRI T2* values). sHJV levels were higher in patients than in controls and in untransfused in comparison with transfused patients. In the transfused group, we also found that sHJV values are significantly related to serum ferritin, cardiac MRI T2* and growth differentiation factor 15 and are sensitive to hepatitis C virus infection. Conclusion These results suggest that sHJV synthesis seems to be affected by an erythropoietic/hypoxic signal in untransfused patients that have severe anaemia, while in regularly transfused subjects, it is influenced by iron stores. |
Author | Salpietro, Carmelo La Rosa, Maria Angela Di Pietro, Angela Ferro, Elisa Visalli, Giuseppa Piraino, Basilia |
Author_xml | – sequence: 1 givenname: Elisa orcidid: 0000-0001-9645-4530 surname: Ferro fullname: Ferro, Elisa email: ferro_elisa@alice.it organization: University Hospital of Messina – sequence: 2 givenname: Angela surname: Di Pietro fullname: Di Pietro, Angela organization: University of Messina – sequence: 3 givenname: Giuseppa surname: Visalli fullname: Visalli, Giuseppa organization: University of Messina – sequence: 4 givenname: Basilia surname: Piraino fullname: Piraino, Basilia organization: University Hospital of Messina – sequence: 5 givenname: Carmelo surname: Salpietro fullname: Salpietro, Carmelo organization: University Hospital of Messina – sequence: 6 givenname: Maria Angela surname: La Rosa fullname: La Rosa, Maria Angela organization: University Hospital of Messina |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27440164$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kFFLwzAQx4NM3Jw--AWk4Is-dCZpljSPIuoUwQf1OVzTK2tJ29k0it_ezk0RQY-Dg-P3P47fPhk1bYOEHDE6Y0OdY7WcMa5SuUMmTFIaU0n1iEyopjwWQrAx2fe-opRyzdQeGXMlBGVSTMjisXUhcxgtsW6r8IqubKKh-w4aXwSPeQRNHoXmx6JfggPvAevSRj5kFdreH5DdApzHw-2ckufrq6fLRXz_cHN7eXEf22SeyFhRKdLCMmmVBpunDCGxKeq5yFTOdT7PBeMiQRQ6RQGyAA2gM0Gl5QDWJlNyurm76tqXgL43dektOgcNtsEblnKp-JwnbEBPfqFVG7pm-M4wzalQiZJr6nhLhazG3Ky6sobu3Xw5GoCzDWC71vsOi2-EUbP2bwb_5tP_wJ7_Ym3ZQ1-2a3-l-y_xVjp8__u0ubpbbBIfnDiWHw |
CitedBy_id | crossref_primary_10_1080_10245332_2017_1311462 crossref_primary_10_1186_s12968_020_00627_x crossref_primary_10_3390_ijms22042204 crossref_primary_10_3390_cancers15041041 |
Cites_doi | 10.1074/jbc.M110.109488 10.1182/blood-2011-01-258467 10.1038/ng1274 10.1016/j.freeradbiomed.2012.08.592 10.1182/blood-2004-06-2422 10.1182/blood-2005-05-1845 10.1186/1471-2407-8-167 10.1182/asheducation-2006.1.29 10.1007/s11255-011-0084-x 10.1074/jbc.M110.173096 10.1182/blood.V96.10.3624 10.1182/blood-2006-06-027631 10.1186/1423-0127-19-83 10.1097/GIM.0b013e3181cd68ed 10.1016/j.bbamcr.2012.01.014 10.1016/j.jhep.2012.06.015 10.1074/jbc.M112.363937 10.1111/j.1365-2141.2007.06728.x 10.1111/ejh.12444 10.1093/clinchem/44.1.40 10.1038/ng.2996 10.1038/nm1629 10.1002/jmri.21781 10.1111/ejh.12122 10.1182/blood-2007-07-100677 10.1182/blood-2008-06-165738 10.1016/j.hoc.2010.08.003 10.1182/blood-2007-09-111567 10.1111/bjh.13815 10.1371/journal.pone.0127518 10.1016/j.bcmd.2012.02.001 10.1007/s00277-009-0879-3 10.1002/hep.22486 10.1182/blood-2012-12-471441 10.2119/2006-00057.Fujita 10.3324/haematol.2010.022129 10.1046/j.1365-2362.2002.0320s1055.x 10.1371/journal.pone.0077267 10.1182/blood-2007-08-109306 10.1074/jbc.273.34.22068 10.1523/JNEUROSCI.4610-03.2004 10.2353/ajpath.2007.060437 10.1038/ng1777 10.1111/ejh.12027 10.1159/000208988 10.1371/journal.pone.0019967 |
ContentType | Journal Article |
Copyright | 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. Copyright © 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd |
Copyright_xml | – notice: 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd – notice: 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. – notice: Copyright © 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QG 7T5 7TM 7TO H94 K9. 7X8 |
DOI | 10.1111/ejh.12786 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Animal Behavior Abstracts Immunology Abstracts Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Oncogenes and Growth Factors Abstracts Animal Behavior Abstracts Nucleic Acids Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic AIDS and Cancer Research Abstracts MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1600-0609 |
EndPage | 74 |
ExternalDocumentID | 27440164 10_1111_ejh_12786 EJH12786 |
Genre | article Journal Article |
GrantInformation_xml | – fundername: Regione Sicilia |
GroupedDBID | --- .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 29G 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAKAS AAMNL AANHP AANLZ AAONW AAQQT AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABDBF ABEML ABJNI ABLJU ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACUHS ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZCM ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFWVQ AFZJQ AHBTC AHEFC AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EAD EAP EAS EBC EBD EBS EGARE EJD EMB EMK EMOBN EPT ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI Q.N Q11 QB0 Q~Q R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ SV3 TEORI TUS UB1 V8K W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR X7M XG1 Y6R YFH YUY ZCG ZGI ZXP ZZTAW ~IA ~WT AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION CGR CUY CVF ECM EIF NPM 7QG 7T5 7TM 7TO AAMMB AEFGJ AGXDD AIDQK AIDYY H94 K9. 7X8 |
ID | FETCH-LOGICAL-c3536-70648fc16c79acd81ea3c8e954b7d29d5d41243ee498e4a6fa9aa9b406c2aacc3 |
IEDL.DBID | DR2 |
ISSN | 0902-4441 1600-0609 |
IngestDate | Tue Aug 05 10:53:57 EDT 2025 Wed Aug 13 06:33:21 EDT 2025 Wed Feb 19 01:59:04 EST 2025 Tue Jul 01 04:33:15 EDT 2025 Thu Apr 24 22:53:39 EDT 2025 Wed Jan 22 16:41:10 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | iron overload hemojuvelin erythropoiesis β-thalassaemia |
Language | English |
License | http://onlinelibrary.wiley.com/termsAndConditions#vor 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3536-70648fc16c79acd81ea3c8e954b7d29d5d41243ee498e4a6fa9aa9b406c2aacc3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0001-9645-4530 |
PMID | 27440164 |
PQID | 1920473761 |
PQPubID | 2045159 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_1826725231 proquest_journals_1920473761 pubmed_primary_27440164 crossref_primary_10_1111_ejh_12786 crossref_citationtrail_10_1111_ejh_12786 wiley_primary_10_1111_ejh_12786_EJH12786 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | January 2017 2017-01-00 2017-Jan 20170101 |
PublicationDateYYYYMMDD | 2017-01-01 |
PublicationDate_xml | – month: 01 year: 2017 text: January 2017 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Hoboken |
PublicationTitle | European journal of haematology |
PublicationTitleAlternate | Eur J Haematol |
PublicationYear | 2017 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | 2010; 12 2006; 91 2012; 287 2004; 104 2011; 117 2012; 1823 2015; 94 2006; 38 2002; 32 2004; 24 2015; 10 2013; 91 2010; 285 2014; 46 2012; 19 2008; 8 2006; 1 2012; 57 2013; 8 2011; 6 2007; 13 2004; 8912 1998; 44 2012; 53 1998; 273 2010; 89 2012; 90 2009; 30 2006; 108 2009; 32 2007; 139 2010; 24 2013; 1221 2007; 170 2000; 96 2005; 106 2008; 48 2015 2010; 173 2012; 48 2008; 112 2008; 111 2009; 1 2012; 44 2004; 436 2010; 95 2011; 286 e_1_2_8_24_1 e_1_2_8_47_1 e_1_2_8_26_1 e_1_2_8_49_1 Nemeth E (e_1_2_8_41_1) 2006; 91 e_1_2_8_3_1 Khumalo H (e_1_2_8_37_1) 1998; 44 e_1_2_8_5_1 e_1_2_8_7_1 e_1_2_8_9_1 e_1_2_8_20_1 e_1_2_8_22_1 Tanno T (e_1_2_8_43_1) 2010; 173 e_1_2_8_45_1 e_1_2_8_17_1 Rodriguez Martinez A (e_1_2_8_25_1) 2004; 8912 e_1_2_8_19_1 e_1_2_8_13_1 e_1_2_8_36_1 e_1_2_8_15_1 e_1_2_8_38_1 e_1_2_8_32_1 e_1_2_8_11_1 e_1_2_8_34_1 e_1_2_8_51_1 e_1_2_8_30_1 e_1_2_8_29_1 e_1_2_8_46_1 e_1_2_8_27_1 e_1_2_8_48_1 e_1_2_8_2_1 e_1_2_8_4_1 e_1_2_8_6_1 e_1_2_8_8_1 e_1_2_8_21_1 e_1_2_8_23_1 e_1_2_8_44_1 Aessopos A (e_1_2_8_28_1) 2009; 1 e_1_2_8_40_1 e_1_2_8_18_1 e_1_2_8_39_1 Centis F (e_1_2_8_42_1) 2000; 96 e_1_2_8_14_1 e_1_2_8_35_1 e_1_2_8_16_1 e_1_2_8_10_1 e_1_2_8_31_1 e_1_2_8_12_1 e_1_2_8_33_1 e_1_2_8_50_1 |
References_xml | – volume: 111 start-page: 5195 year: 2008 end-page: 204 article-title: Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin publication-title: Blood – volume: 287 start-page: 35104 year: 2012 end-page: 17 article-title: Neogenin interacts with matriptase‐2 to facilitate hemojuvelin cleavage publication-title: J Biol Chem – volume: 12 start-page: 61 year: 2010 end-page: 76 article-title: Beta‐thalassaemia publication-title: Genet Med – volume: 111 start-page: 583 year: 2008 end-page: 587 article-title: Effect of transfusional iron intake on response to chelation therapy in β‐thalassaemia major publication-title: Blood – volume: 1823 start-page: 1434 year: 2012 end-page: 43 article-title: Hepcidin and iron homeostasis publication-title: Biochim Biophys Acta – volume: 46 start-page: 678 year: 2014 end-page: 84 article-title: Identification of erythroferrone as an erythroid regulator of iron metabolism publication-title: Nat Genet – volume: 111 start-page: 924 year: 2008 end-page: 31 article-title: Furin‐mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis publication-title: Blood – volume: 112 start-page: 5241 year: 2008 end-page: 4 article-title: Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anaemia type I publication-title: Blood – volume: 91 start-page: 74 year: 2013 end-page: 84 article-title: Serum hepcidin levels and muscle iron proteins in humans injected with low‐ or high‐dose erythropoietin publication-title: Eur J Haematol – volume: 19 start-page: 83 year: 2012 article-title: Tumour necrosis factor alpha downregulates human hemojuvelin expression via a novel response element within its promoter publication-title: J Biomed Sci – volume: 30 start-page: 62 year: 2009 end-page: 8 article-title: Multicenter validation of the magnetic resonance T2* technique for segmental and global quantification of myocardial iron publication-title: J Magn Reson Imaging – volume: 94 start-page: 404 year: 2015 end-page: 12 article-title: Endocrinopathies metabolic disorders and iron overload in major and intermedia thalassaemia: serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment publication-title: Eur J Haematol – volume: 13 start-page: 97 year: 2007 end-page: 104 article-title: Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis C publication-title: Mol Med – volume: 8912 start-page: 1441 year: 2004 end-page: 5 article-title: Hepatic and extrahepatic expression of the new iron regulatory protein Hemojuvelin publication-title: Haematologica – volume: 1 start-page: 29 year: 2006 end-page: 39 article-title: Hepcidin and its role in regulating systemic iron metabolism publication-title: Hematology Am Soc Hematol Educ Program – volume: 285 start-page: 16416 year: 2010 end-page: 23 article-title: The role of hepatocyte hemojuvelin in the regulation of bone morphogenic protein‐6 and hepcidin expression publication-title: J Biol Chem – volume: 10 start-page: e0127518 year: 2015 article-title: Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma publication-title: PLoS One – volume: 117 start-page: 4425 year: 2011 end-page: 33 article-title: Hepcidin and iron regulation 10 years later publication-title: Blood – volume: 106 start-page: 2884 year: 2005 end-page: 9 article-title: Competitive regulation of hepcidin mRNA by soluble and cell‐associated hemojuvelin publication-title: Blood – year: 2015 article-title: HIF1α and Glut1 receptor in transfused and untransfused thalassemic patients publication-title: Brit J Haematol – volume: 96 start-page: 3624 year: 2000 end-page: 9 article-title: The importance of erythroid expansion in determining the extent of apoptosis in erythroid precursors in patients with beta‐thalassaemia major publication-title: Blood – volume: 32 start-page: 55 year: 2002 end-page: 60 article-title: Oxidative status and malondialdehyde in b‐thalassaemia patients publication-title: Eur J Clin Invest – volume: 48 start-page: 233 year: 2012 end-page: 7 article-title: Hepcidin is correlated to soluble hemojuvelin but not to increased GDF15 during pregnancy publication-title: Blood Cells Mol Dis – volume: 286 start-page: 4090 year: 2011 end-page: 7 article-title: Regulation of type II transmembrane serine proteinase TMPRSS6 by hypoxia‐inducible factors: new link between hypoxia signaling and iron homeostasis publication-title: J Biol Chem – volume: 95 start-page: 2031 year: 2010 end-page: 7 article-title: Immunoassay for human serum Hemojuvelin publication-title: Haematologica – volume: 13 start-page: 1096 year: 2007 end-page: 101 article-title: High levels of GDF15 in thalassaemia suppress expression of the iron regulatory protein hepcidin publication-title: Nat Med – volume: 89 start-page: 585 year: 2010 end-page: 9 article-title: Absence of cardiac siderosis despite hepatic iron overload in Italian patients with thalassaemia intermedia: an MRI T2* study publication-title: Ann Hematol – volume: 139 start-page: 138 year: 2007 end-page: 47 article-title: Different regulatory elements are required for response of hepcidin to interleukin‐6 and bone morphogenetic proteins 4 and 9 publication-title: Brit J Haematol – volume: 108 start-page: 3204 year: 2006 end-page: 9 article-title: Interleukin‐6 induces hepcidin expression through STAT3 publication-title: Blood – volume: 90 start-page: 31 year: 2012 end-page: 6 article-title: High levels of soluble serum hemojuvelin in patients with congenital dyserythropoietic anaemia type I publication-title: Eur J Haematol – volume: 173 start-page: 184 year: 2010 end-page: 90 article-title: Growth differentiation factor 15 in erythroid health and disease publication-title: Curr Opin Hematol – volume: 48 start-page: 1420 year: 2008 end-page: 9 article-title: Hepatitis C virus‐induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity publication-title: Hepatology – volume: 24 start-page: 808 year: 2004 end-page: 18 article-title: Repulsive guidance molecule RGM gene function is required for neural tube closure but not retinal to pography in the mouse visual system publication-title: J Neurosci – volume: 1221 start-page: 124 year: 2013 end-page: 33 article-title: Transfusion suppresses erythropoiesis and increases hepcidin in adult patients with β‐thalassaemia major: a longitudinal study publication-title: Blood – volume: 44 start-page: 1805 year: 2012 end-page: 11 article-title: Is hemojuvelin a possible new player in iron metabolism in hemodialysis patients? publication-title: Int Urol Nephr – volume: 6 start-page: e19967 year: 2011 article-title: Growth differentiation factor 15 is induced by hepatitis C virus infection and regulates hepatocellular carcinoma‐related genes publication-title: PLoS One – volume: 24 start-page: 1089 year: 2010 end-page: 107 article-title: Anaemia ineffective erythropoiesis and hepcidin: interacting factors in abnormal iron metabolism leading to iron overload in β‐thalassaemia publication-title: Hematol Onc Clin North Am – volume: 8 start-page: 167 year: 2008 article-title: Expression of hepcidin mRNA is uniformly suppressed in hepatocellular carcinoma publication-title: BMC Cancer – volume: 104 start-page: 4308 year: 2004 end-page: 10 article-title: Expression of Rgmc the murine ortholog of hemojuvelin gene is modulated by development and inflammation but not by iron status or erythropoietin publication-title: Blood – volume: 38 start-page: 531 year: 2006 end-page: 9 article-title: Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression publication-title: Nat Genet – volume: 1 start-page: 2009002 year: 2009 article-title: Cardiac function and iron chelation in thalassaemia major and intermedia: a review of the underlying pathophysiology and approach to chelation management publication-title: Mediterr J Hematol Infect Dis – volume: 53 start-page: 1829 year: 2012 end-page: 37 article-title: Oxidative damage and genotoxicity biomarkers in transfused and untransfused thalassaemic subjects publication-title: Free Radic Biol Med – volume: 170 start-page: 497 year: 2007 end-page: 504 article-title: Repression of repulsive guidance molecule C during inflammation is independent of Hfe and involves tumor necrosis factor‐alpha publication-title: Am J Pathol – volume: 91 start-page: 727 year: 2006 end-page: 32 article-title: Hepcidin and iron‐loading anaemias publication-title: Haematologica – volume: 44 start-page: 40 year: 1998 end-page: 4 article-title: Gangaidzo IT‐ Serum transferrin receptors are decreased in the presence of iron overload publication-title: Clin Chem – volume: 57 start-page: 1052 year: 2012 end-page: 60 article-title: The hemochromatosis proteins HFE TfR2 and HJV form a membrane‐associated protein complex for hepcidin regulation publication-title: J Hepatol – volume: 273 start-page: 22068 year: 1998 end-page: 74 article-title: Co‐trafficking of HFE a nonclassical major histocompatibility complex class I protein with the transferrin receptor implies a role in intracellular iron regulation publication-title: J Biol Chem – volume: 8 start-page: 77267 year: 2013 article-title: proximity ligation assays indicate that hemochromatosis proteins Hfe and transferrin receptor 2 Tfr2 do not interact publication-title: PLoS One – volume: 32 start-page: 71 year: 2009 end-page: 6 article-title: Hemojuvelin: the hepcidin story continues publication-title: Kidney Blood Press Res – volume: 436 start-page: 77 year: 2004 end-page: 82 article-title: Mutations in HFE2 cause iron overload in chromosome 1q‐linked juvenile hemochromatosis publication-title: Nat Genet – ident: e_1_2_8_6_1 doi: 10.1074/jbc.M110.109488 – ident: e_1_2_8_5_1 doi: 10.1182/blood-2011-01-258467 – ident: e_1_2_8_30_1 doi: 10.1038/ng1274 – ident: e_1_2_8_51_1 doi: 10.1016/j.freeradbiomed.2012.08.592 – ident: e_1_2_8_44_1 doi: 10.1182/blood-2004-06-2422 – ident: e_1_2_8_9_1 doi: 10.1182/blood-2005-05-1845 – ident: e_1_2_8_48_1 doi: 10.1186/1471-2407-8-167 – ident: e_1_2_8_3_1 doi: 10.1182/asheducation-2006.1.29 – ident: e_1_2_8_24_1 doi: 10.1007/s11255-011-0084-x – ident: e_1_2_8_10_1 doi: 10.1074/jbc.M110.173096 – volume: 96 start-page: 3624 year: 2000 ident: e_1_2_8_42_1 article-title: The importance of erythroid expansion in determining the extent of apoptosis in erythroid precursors in patients with beta‐thalassaemia major publication-title: Blood doi: 10.1182/blood.V96.10.3624 – ident: e_1_2_8_18_1 doi: 10.1182/blood-2006-06-027631 – ident: e_1_2_8_20_1 doi: 10.1186/1423-0127-19-83 – ident: e_1_2_8_2_1 doi: 10.1097/GIM.0b013e3181cd68ed – ident: e_1_2_8_4_1 doi: 10.1016/j.bbamcr.2012.01.014 – ident: e_1_2_8_13_1 doi: 10.1016/j.jhep.2012.06.015 – ident: e_1_2_8_31_1 doi: 10.1074/jbc.M112.363937 – ident: e_1_2_8_19_1 doi: 10.1111/j.1365-2141.2007.06728.x – ident: e_1_2_8_33_1 doi: 10.1111/ejh.12444 – volume: 91 start-page: 727 year: 2006 ident: e_1_2_8_41_1 article-title: Hepcidin and iron‐loading anaemias publication-title: Haematologica – volume: 44 start-page: 40 year: 1998 ident: e_1_2_8_37_1 article-title: Gangaidzo IT‐ Serum transferrin receptors are decreased in the presence of iron overload publication-title: Clin Chem doi: 10.1093/clinchem/44.1.40 – ident: e_1_2_8_17_1 doi: 10.1038/ng.2996 – ident: e_1_2_8_16_1 doi: 10.1038/nm1629 – ident: e_1_2_8_27_1 doi: 10.1002/jmri.21781 – ident: e_1_2_8_15_1 doi: 10.1111/ejh.12122 – volume: 173 start-page: 184 year: 2010 ident: e_1_2_8_43_1 article-title: Growth differentiation factor 15 in erythroid health and disease publication-title: Curr Opin Hematol – ident: e_1_2_8_11_1 doi: 10.1182/blood-2007-07-100677 – ident: e_1_2_8_39_1 doi: 10.1182/blood-2008-06-165738 – ident: e_1_2_8_40_1 doi: 10.1016/j.hoc.2010.08.003 – ident: e_1_2_8_29_1 doi: 10.1182/blood-2007-09-111567 – volume: 8912 start-page: 1441 year: 2004 ident: e_1_2_8_25_1 article-title: Hepatic and extrahepatic expression of the new iron regulatory protein Hemojuvelin publication-title: Haematologica – ident: e_1_2_8_35_1 doi: 10.1111/bjh.13815 – ident: e_1_2_8_46_1 doi: 10.1371/journal.pone.0127518 – ident: e_1_2_8_23_1 doi: 10.1016/j.bcmd.2012.02.001 – ident: e_1_2_8_32_1 doi: 10.1007/s00277-009-0879-3 – ident: e_1_2_8_50_1 doi: 10.1002/hep.22486 – ident: e_1_2_8_36_1 doi: 10.1182/blood-2012-12-471441 – ident: e_1_2_8_49_1 doi: 10.2119/2006-00057.Fujita – ident: e_1_2_8_21_1 doi: 10.3324/haematol.2010.022129 – ident: e_1_2_8_34_1 doi: 10.1046/j.1365-2362.2002.0320s1055.x – ident: e_1_2_8_14_1 doi: 10.1371/journal.pone.0077267 – ident: e_1_2_8_26_1 doi: 10.1182/blood-2007-08-109306 – ident: e_1_2_8_12_1 doi: 10.1074/jbc.273.34.22068 – ident: e_1_2_8_38_1 doi: 10.1523/JNEUROSCI.4610-03.2004 – ident: e_1_2_8_45_1 doi: 10.2353/ajpath.2007.060437 – ident: e_1_2_8_8_1 doi: 10.1038/ng1777 – ident: e_1_2_8_22_1 doi: 10.1111/ejh.12027 – volume: 1 start-page: 2009002 year: 2009 ident: e_1_2_8_28_1 article-title: Cardiac function and iron chelation in thalassaemia major and intermedia: a review of the underlying pathophysiology and approach to chelation management publication-title: Mediterr J Hematol Infect Dis – ident: e_1_2_8_7_1 doi: 10.1159/000208988 – ident: e_1_2_8_47_1 doi: 10.1371/journal.pone.0019967 |
SSID | ssj0002917 |
Score | 2.1600409 |
Snippet | Objective
The hemojuvelin‐bone morphogenetic protein axis is the principal iron‐dependent mechanism of hepcidin regulation. The determination of soluble... The hemojuvelin-bone morphogenetic protein axis is the principal iron-dependent mechanism of hepcidin regulation. The determination of soluble hemojuvelin... Objective The hemojuvelin-bone morphogenetic protein axis is the principal iron-dependent mechanism of hepcidin regulation. The determination of soluble... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 67 |
SubjectTerms | Adult Anemia Biomarkers Blood diseases Blood Transfusion Case-Control Studies Erythrocyte Indices Erythropoiesis Female Ferritin GPI-Linked Proteins - blood Heart diseases hemojuvelin Hepatitis C Hepcidin Hepcidins - blood Humans Hypoxia Iron iron overload Iron Overload - etiology Liver Magnetic resonance imaging Male Middle Aged Reticulocytes Thalassemia - blood Thalassemia - complications Thalassemia - therapy Young Adult β‐thalassaemia |
Title | Soluble hemojuvelin in transfused and untransfused thalassaemic subjects |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fejh.12786 https://www.ncbi.nlm.nih.gov/pubmed/27440164 https://www.proquest.com/docview/1920473761 https://www.proquest.com/docview/1826725231 |
Volume | 98 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JS8QwFA4yB_HivowbVTx46TBN0yV4Ep1hEPQgDsxBKEn6yjCOHbGtB3-9L-nijAuI0EOX1ybNy0u-vLx8IeQMYhr6HALb6zrKZoJKW1IhbcfHtjCJgbnGoX975w-G7GbkjZbIRb0WpuSHaBxu2jJMe60NXMhszshhMu44NAg13bbj-po3__r-kzqKcrPbrg47tBn2-RWrkI7iad5c7Iu-AcxFvGo6nP4aeayzWsaZPHWKXHbU-xcWx3_-yzpZrYCodVnWnA2yBOkmWb6tptq3yEA7zOQUrDE8zybFm163buGRG6RbZBBbIo2tIp27kY_1qsxM6IB7Kyuk9vFk22TY7z1cDexq2wVbuZ7r2wGilDBRjq8CLlQcOiBcFQL3mAxiymMv1jtWuwCMh8CEnwguBJeIDBQVQil3h7TSWQp7xHKE1_WBBYlIOEOowsGVHC8lBw-_yNvkvFZApCpOcr01xjSqxyZYMpEpmTY5bURfSiKOn4QOay1GlS1mEWLYLguwIXXa5KR5jFakp0ZECrMCZXCUFVAclKPMbqn9JhXDoYijSsys0eHvyUe9m4E52f-76AFZoRopGK_OIWnlrwUcIc7J5bGp0B-xS_iD |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB7xkAqXQkuhCwtNKw69ZLVxnIclLlULSinLoQKJC4psZ6LVQrNVk_TQX9-x8-hSQEJIOeQxiR2Px_5mPJ4BOMSMxaHAyA3Gnna5ZMpVTCrXC2kszDPkvjXoT87D5JKfXgVXS3DU7YVp4kP0BjcjGXa8NgJuDNILUo6z6chjURwuwyonoGFUry_f_wWPYsLm2zWOhy6nWb-NK2T8ePpX785G9yDmXcRqp5yTDbjuKtt4mtyM6kqN9J__4jg-92824WWLRZ1PTed5BUtYvIYXk3a1fQsSYzNTt-hM8cd8Vv82W9cdOioLdusSM0cWmVMXCzeqqdmYWUrjc--UtTJmnvINXJ4cX3xO3Dbzgqv9wA_diIBKnGsv1JGQOos9lL6OUQRcRRkTWZCZpNU-IhcxchnmUkgpFIEDzaTU2t-GlWJe4FtwPBmMQ-RRLnPBCa0I9JWgSyUwoC-KAXzsOJDqNiy5yY5xm3bqCbVMaltmAB960p9NLI6HiIYdG9NWHMuUYOyYRzSWegN43z8mQTKrI7LAeU00pGhFjPRyotlp2N-XYsMokmJJlbVMfLz49Pg0sSe7Tyd9B2vJxeQsPft6_m0P1pkBDtbIM4SV6leN-wR7KnVge_dfPqj8og |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB5RKqFegLYUltI2rXrgktXGcZxYnBBltaUFVVWROFSK_JhoxSOLSMKBX9-x8yj0IVWVcshjEjsej_3NeDwD8B4ty4TENEwmkQm5YjrUTOkwEjQWFhZ57A36xydidsqPzpKzJdjr98K08SEGg5uTDD9eOwG_tsU9Icfz-ThiaSYewWMuCEk4RPT1Z-woJn26Xed3GHKa9LuwQs6NZ3j14WT0G8J8CFj9jDNdg-99XVtHk4txU-uxufsljON__sw6rHZINNhvu85TWMLyGawcd2vtz2HmLGb6EoM5Xi3Om1u3cT2go_ZQt6nQBqq0QVPeu1HP3bbMSjmP-6BqtDPyVBtwOj38djALu7wLoYmTWIQpwZSsMJEwqVTGZhGq2GQoE65Ty6RNrEtZHSNymSFXolBSKakJGhimlDHxC1guFyVuQRCpZCKQp4UqJCesIjHWki61xIS-KEew2zMgN11Qcpcb4zLvlRNqmdy3zAjeDaTXbSSOPxHt9FzMO2GscgKxE57SSBqN4O3wmMTIrY2oEhcN0ZCalTLSyolms-X-UIoPokhqJVXW8_DvxeeHRzN_sv3vpG9g5cuHaf7548mnl_CEOdTgLTw7sFzfNPiKME-tX_u-_QNQtPtR |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Soluble+hemojuvelin+in+transfused+and+untransfused+thalassaemic+subjects&rft.jtitle=European+journal+of+haematology&rft.au=Ferro%2C+Elisa&rft.au=Di+Pietro%2C+Angela&rft.au=Visalli%2C+Giuseppa&rft.au=Piraino%2C+Basilia&rft.date=2017-01-01&rft.issn=1600-0609&rft.eissn=1600-0609&rft.volume=98&rft.issue=1&rft.spage=67&rft_id=info:doi/10.1111%2Fejh.12786&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0902-4441&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0902-4441&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0902-4441&client=summon |